A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardio

Project: Other project

StatusFinished
Effective start/end date3/5/137/23/16

Funding

  • GlaxoSmithKline Pharmaceuticals: $4,128.80